Gene-edited cells that evade rejection present promise in kind 1 diabetes

The primary human trial of insulin-producing cells which have been gene-edited to evade immune assault is successful up to now. The cells have survived and produced insulin for a month after being injected right into a 42-year-old man with kind 1 diabetes early in December.

As a precaution, solely a small variety of insulin-producing beta cells have been injected right into a forearm muscle on this preliminary check, so the person nonetheless wants insulin injections. It additionally stays to be seen how lengthy the…